MCM
RMD icon

Marsico Capital Management’s ResMed RMD Stock Holding History

Marsico Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-34,911
Closed -$4.72M – 89
2019
Q3 		$4.72M Hold
34,911
– – 0.18% 62
2019
Q2 		$4.26M Buy
34,911
+10,507
+43% +$1.16M 0.15% 66
2019
Q1 		$2.54M Buy
+24,404
New +$2.52M 0.09% 76

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marsico Capital Management's RMD Position: Q4 2019 in Review

Marsico Capital Management sold out of ResMed (RMD) in Q4 2019, closing a stake of 34,911 shares — an estimated $4.72M sold.

Marsico Capital Management first reported a position in RMD in Q1 2019 and held it in 3 quarters. The position peaked at $4.72M in Q3 2019. 559 funds tracked by Wall St. Rank hold RMD as of Q4 2019.

  • Marsico Capital Management reported no remaining ResMed position as of Q4 2019 after selling out during the quarter.
  • Marsico Capital Management sold 34,911 ResMed shares in Q4 2019, an estimated $4.72M.
  • Marsico Capital Management first reported a position in ResMed in Q1 2019 and held it in 3 quarters.
  • Marsico Capital Management's ResMed position peaked at $4.72M in Q3 2019.
  • 559 funds tracked by Wall St. Rank held ResMed as of Q4 2019.

Based on Marsico Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.